CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)

PartnershipVEPPANUPositive
AI Analysis

Summary

Onco360 has been selected as a national pharmacy partner for VEPPANU (vepdegestrant), a drug by Rigel Pharmaceuticals. This represents a routine commercial partnership announcement for drug distribution.

Importance:3/10
Sentiment:
0.50
partnershippharmacy distributioncommercial
Related Companies

Read the original article

Published by yahoo_finance on July 29, 2026 8:30 PM

Read Original